HOLX

Hologic
D

HOLX

54.180
USD
-3.06
(-5.35%)
مغلق
حجم التداول
377,192
الربح لكل سهم
4
العائد الربحي
-
P/E
17
حجم السوق
12,157,429,178
أصول ذات صلة
ABT
ABT
1.930
(1.47%)
132.820 USD
BDX
BDX
-0.770
(-0.45%)
168.780 USD
DGX
DGX
0.630
(0.36%)
178.000 USD
ISRG
ISRG
12.25
(2.37%)
529.20 USD
R
RGEN
4.530
(3.30%)
141.720 USD
SYK
SYK
4.11
(1.10%)
378.26 USD
T
TDOC
0.09000
(1.29%)
7.06500 USD
TMO
TMO
3.67
(0.87%)
423.51 USD
المزيد
الأخبار المقالات

العنوان: Hologic

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.